The ready-to-use lentiviral particles of Lenti-p53 TCR (Cysteine-modiﬁed)-VP is packaged using 3rd generation of lentiviral packaging system, in which the gene of Murinized (from Human) TCR will be driven by a CMV promotor. The target gene of TCR packaged in lentiviral particles could be used for high efficency tranduction of T cells and stably integrated expression.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|TCR-L091||Murinized (from Human) anti-TP53 (LLGRNSFEV) T Cell Receptor, pMSGV1|
|TCR-L089||Human anti-TP53 (LLGRNSFEV) T Cell Receptor, pSFG|
|TCR-L092||Murinized (from Human) anti-TP53 (LLGRNSFEV) T Cell Receptor[Cysteine-modiﬁed], pMSGV1|
|VP-TCR-C531||Lenti-p53 Murinized T cell receptor Viral Particle|
|VP-TCR-C529||Lenti-p53 T cell receptor (Single-chain TCR) Viral Particle|
|TCR-L090||Human anti-TP53 (LLGRNSFEV) T Cell Receptor, pMSGV1|
|TCR-L091Z||Murinized anti-p53 (aa264-272) T cell receptor (Cysteine-modiﬁed), pCDTCR1|
|TCR-L088Z||Human anti-p53 (aa264-272) T cell receptor (Single-chain TCR), pCDTCR1|
|TCR-L322||Human anti-p53 T cell receptor (p-149), pCDTCR1|
|TCR-L090Z||Murinized anti-p53 (aa264-272) T cell receptor, pCDTCR1|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved